<article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle http://dtd.nlm.nih.gov/2.0/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Biochim Biophys Acta</journal-id>
      <journal-title-group>
        <journal-title>Biochimica et Biophysica Acta</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0006-3002</issn>
      <publisher>
        <publisher-name>Elsevier Pub. Co</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3245891</article-id>
      <article-id pub-id-type="pmid">21777565</article-id>
      <article-id pub-id-type="publisher-id">BBAMEM80609</article-id>
      <article-id pub-id-type="doi">10.1016/j.bbamem.2011.07.001</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The hERG K<sup>+</sup> channel S4 domain L532P mutation: Characterization at 37 °C</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Yi H.</given-names>
          </name>
          <xref rid="af0005" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Colenso</surname>
            <given-names>Charlotte K.</given-names>
          </name>
          <xref rid="af0010" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sessions</surname>
            <given-names>Richard B.</given-names>
          </name>
          <xref rid="af0010" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dempsey</surname>
            <given-names>Christopher E.</given-names>
          </name>
          <xref rid="af0010" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hancox</surname>
            <given-names>Jules C.</given-names>
          </name>
          <email>Jules.hancox@bristol.ac.uk</email>
          <xref rid="af0005" ref-type="aff">a</xref>
          <xref rid="cr0005" ref-type="corresp">⁎</xref>
        </contrib>
      </contrib-group>
      <aff id="af0005"><label>a</label>School of Physiology and Pharmacology and Cardiovascular Research Laboratories, Medical Sciences Building, University of Bristol, University Walk, Bristol BS8 1TD, UK</aff>
      <aff id="af0010"><label>b</label>School of Biochemistry, Medical Sciences Building, University of Bristol, University Walk, Bristol BS8 1TD, UK</aff>
      <author-notes>
        <corresp id="cr0005"><label>⁎</label>Corresponding author. Tel.: + 44 117 3312292; fax: + 44 117 331 2288. <email>Jules.hancox@bristol.ac.uk</email></corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <month>10</month>
        <year>2011</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="ppub"/>. -->
      <pub-date pub-type="ppub">
        <month>10</month>
        <year>2011</year>
      </pub-date>
      <volume>1808</volume>
      <issue>10</issue>
      <fpage>2477</fpage>
      <lpage>2487</lpage>
      <history>
        <date date-type="received">
          <day>4</day>
          <month>5</month>
          <year>2011</year>
        </date>
        <date date-type="rev-recd">
          <day>28</day>
          <month>6</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>6</day>
          <month>7</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2011 Elsevier B.V.</copyright-statement>
        <copyright-year>2011</copyright-year>
        <copyright-holder>Elsevier B.V.</copyright-holder>
        <license>
          <license-p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract>
        <p><italic>hERG</italic> (<italic>human Ether-à-go-go Related Gene</italic>) is responsible for ion channels mediating rapid delayed rectifier potassium current, I<sub>Kr</sub>, which is key to cardiac action potential repolarization. Gain-of-function <italic>hERG</italic> mutations give rise to the SQT1 variant of the Short QT Syndrome (SQTS). Reggae mutant zebrafish, with a S4 <italic>zERG</italic> mutation (Leucine499Proline; L499P), display arrhythmic features analogous to those seen in the SQTS. The affected S4 domain ERG residue is highly conserved. This study was executed to determine how the homologous hERG mutation (L532P) influences channel function at 37 °C. Whole-cell measurements of current (I<sub>hERG</sub>) were made from HEK 293 cells expressing WT or L532P hERG. The half maximal activation voltage (V<sub>0.5</sub>) of L532P I<sub>hERG</sub> was positively shifted by ~+36 mV compared to WT I<sub>hERG</sub>; however at negative voltages a pronounced L532P I<sub>hERG</sub> was observed. Both activation and deactivation time-courses were accelerated for L532P I<sub>hERG</sub>. The inactivation V<sub>0.5</sub> for L532P I<sub>hERG</sub> was shifted by ~+32 mV. Under action potential (AP) voltage-clamp, L532P I<sub>hERG</sub> exhibited a dome-shaped current peaking at ~+16 mV, compared to ~−31 mV for WT-I<sub>hERG</sub>. The L532P mutation produced an ~ 5-fold increase in the IC<sub>50</sub> for dronedarone inhibition of I<sub>hERG</sub>. Homology modeling indicated that the L532 residue within the S4 helix lies closely apposed to the S5 region of an adjacent hERG subunit. Alterations to the S4 domain structure and, potentially, to interactions between adjacent hERG subunits are likely to account for the functional effects of this mutation.</p>
      </abstract>
      <abstract abstract-type="graphical">
        <title>Highlights</title>
        <p>► The L532P hERG channel mutation was studied at 37 °C. ► The L532P mutation significantly modified activation and inactivation kinetics. ► hERG current elicited by AP voltage clamp was also significantly altered. ► The mutation also decreased channel sensitivity to inhibition by dronedarone. ► Homology modeling provides a structural context for the effects of this mutation.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Arrhythmia</kwd>
        <kwd>Dronedarone</kwd>
        <kwd>hERG</kwd>
        <kwd>I<sub>Kr</sub></kwd>
        <kwd>Short QT syndrome</kwd>
        <kwd>Potassium channel</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="s0005">
      <label>1</label>
      <title>Introduction</title>
      <p>The cardiac rapid delayed rectifier potassium channel passes ionic current (I<sub>Kr</sub>) that plays an important role in cardiac action potential (AP) repolarization <xref rid="bb0005 bb0010" ref-type="bibr">[1,2]</xref>. The pore-forming subunit of I<sub>Kr</sub> channels is encoded by <italic>human Ether-à-go-go-Related Gene</italic> (<italic>hERG</italic>; alternative nomenclatures <italic>KCNH2</italic> or Kv11.1) <xref rid="bb0015 bb0020" ref-type="bibr">[3,4]</xref>. Loss-of-function hERG mutations are responsible for the LQT2 variant of congenital long QT syndrome (LQTS), while unique structural features of the hERG channel render it highly susceptible to pharmacological blockade and make it an important target for antiarrhythmic drugs and drugs associated with the acquired form of the LQTS <xref rid="bb0010 bb0025 bb0030 bb0035" ref-type="bibr">[2,5–7]</xref>.</p>
      <p>Within the last decade the hERG channel has also been implicated in the genetic ‘short QT syndrome’ (SQTS), a condition characterized by abbreviated QT intervals, poor rate adaptation of the QT interval and an increased susceptibility to both atrial and ventricular arrhythmias and to sudden death <xref rid="bb0040 bb0045" ref-type="bibr">[8,9]</xref>. The first variant of the SQTS to be genotyped (SQT1) was found to be caused by base substitutions leading to a single amino-acid change (Asn588Lys; ‘N588K’) in the S5-Pore linker of the hERG channel <xref rid="bb0050 bb0055" ref-type="bibr">[10,11]</xref>. Detailed electrophysiological analysis of N588K-hERG showed the dominant effect of the mutation to be a marked right-ward shift (by ~+60 to + 90 mV) in the voltage-dependence of inactivation of hERG current (I<sub>hERG</sub>), leading to substantially increased current during the repolarizing phases of both ventricular and atrial APs <xref rid="bb0050 bb0060 bb0065 bb0070" ref-type="bibr">[10,12–14]</xref>. Due to its markedly altered inactivation properties, the N588K hERG mutant also exhibits markedly reduced sensitivity to Class III antiarrhythmic I<sub>Kr</sub> inhibitors (sotalol, E-4031), with much less of an attenuation of the effect of Class Ia drugs (quinidine, disopyramide) <xref rid="bb0050 bb0075 bb0080" ref-type="bibr">[10,15,16]</xref>. A second SQT1 hERG channel gain-of-function pore mutation (Thr618Ile; ‘T618I’ located in the channel pore-helix), which also exhibits modified inactivation kinetics, has recently been reported <xref rid="bb0160" ref-type="bibr">[32]</xref>. There is no genetically accurate mammalian model of SQT1; consequently, efforts to understand the basis of arrhythmogenicity in this form of the SQTS have relied either on computer modeling (e.g. <xref rid="bb0085 bb0090 bb0095 bb0100" ref-type="bibr">[17–20]</xref>) or upon the application of K<sup>+</sup> channel openers to tissue preparations <xref rid="bb0105 bb0110 bb0115 bb0120" ref-type="bibr">[21–24]</xref>.</p>
      <p>The only existing vertebrate genetic model of a hERG-linked SQTS-like arrhythmogenic syndrome is the zebrafish Reggae mutant <xref rid="bb0125" ref-type="bibr">[25]</xref>. Reggae mutant zebrafish embryos exhibit action potential abbreviation, cardiac fibrillation and intermittent cardiac arrest, while adult fish exhibit shorted QT<sub>c</sub> intervals <xref rid="bb0125" ref-type="bibr">[25]</xref>. Positional cloning has identified the mutation responsible as residing in exon 8 of the zebrafish ERG channel (zERG) <xref rid="bb0125" ref-type="bibr">[25]</xref>. A leucine to proline substitution (L499P) was found in the S4 (voltage-sensor) region of zERG. This region is highly conserved across species (<xref rid="f0005" ref-type="fig">Fig. 1</xref>A and see <xref rid="bb0125" ref-type="bibr">[25]</xref>) with the equivalent mutation to hERG being L532P. Electrophysiological analysis of L499P zERG and L532P hERG in <italic>Xenopus</italic> oocytes has shown gain-of-function kinetic effects of the mutation, with alterations to activation and inactivation voltage-dependence over physiologically relevant membrane potentials <xref rid="bb0125" ref-type="bibr">[25]</xref>. Due to the fact that the L532 residue is located in a different segment of the channel to those in which the N588 and T618 residues reside, detailed information on the nature of the distinct kinetic changes produced by the L532P hERG mutation and its net effect on repolarizing current profile would provide valuable comparative information to that presently available for these human short QT hERG mutations. The kinetics of I<sub>hERG</sub> have been shown to exhibit a complex temperature dependence, making it difficult to extrapolate directly results obtained at ambient temperature to human body temperature <xref rid="bb0130" ref-type="bibr">[26]</xref>; properties of recombinant hERG channels also appear to be closest to those of native I<sub>Kr</sub> when channels are expressed in a mammalian cell line and studied at human body temperature <xref rid="bb0010 bb0135" ref-type="bibr">[2,27]</xref>. Consequently, the present study was undertaken to determine the effects of the L532P mutation on I<sub>hERG</sub> recorded from mammalian cells at 37 °C. Our results: (i) constitute quantitative information on the effects of the L532P mutation on both voltage and time-dependent kinetics of I<sub>hERG</sub>; (ii) demonstrate the ability of this mutation to alter the hERG channel's sensitivity to pharmacological inhibition and (iii) indicate the structural context for the affected amino-acid residue of the channel.</p>
    </sec>
    <sec sec-type="materials|methods" id="s0010">
      <label>2</label>
      <title>Material and methods</title>
      <sec id="s0015">
        <label>2.1</label>
        <title>Mutagenesis</title>
        <p>The L532P hERG mutation was generated using the QuickChange® site-directed mutagenesis kit (Stratagene, La Jolla, CA). In brief, a pair of complementary oligonucleotide primers containing the mutation (forward primer sequence 5′CTGCTGCGGCCGGTGCGCGTG3′ and reverse primer sequence 5′CACGCGCACCGGCCGCAGCAG3′, synthesized by Sigma-Genosys, Haverhill, UK) was used in a PCR reaction (95 °C for 1 min, 60 °C for 1 min, 68 °C for 16 min for 18 cycles) by using hERG in a modified pcDNA3.0 vector as a DNA template. A DpnI digest of the PCR mix was then performed for 1 h at 37 °C. Competent DH5<italic>α Escherichia coli</italic> (Invitrogen, Paisley, UK) were transformed using standard procedures. The mutation was confirmed by sequencing of the entire open reading frame (Eurofins MWG Operon, Ebersberg, Germany).</p>
      </sec>
      <sec id="s0020">
        <label>2.2</label>
        <title>Cell culture and transfection</title>
        <p>HEK 293 cells (European Collection of Cell Cultures, Porton Down, UK) were maintained at 37 °C, 5% CO<sub>2</sub> in Dulbecco's minimum essential medium with Glutamax-1 (DMEM; Gibco, Paisley, UK). This was supplemented with 10% fetal bovine serum, 50 μg ml<sup>− 1</sup> gentamycin (Gibco, Paisley, UK). Cells were transiently transfected with cDNA plasmids encoding WT and mutant hERG using Lipofectamine LTX (Invitrogen, Paisley, UK) according to the manufacturer's instructions. Expression plasmid encoding CD8 was also added (in pIRES, donated by Dr I Baró, University of Nantes, France) to be used as a successful marker of transfection. Recordings were performed 12–72 h after transfection. Successfully transfected cells (positive to CD8) were identified using Dynabeads® (Invitrogen, Paisley, UK).</p>
      </sec>
      <sec id="s0025">
        <label>2.3</label>
        <title>Solutions for electrophysiological recordings</title>
        <p>Once in the recording chamber, cells were superfused with normal Tyrode's containing (in mM): 140 NaCl, 4 KCl, 2.5 CaCl<sub>2</sub>, 1 MgCl<sub>2</sub>, 10 Glucose, and 5 HEPES (titrated to pH of 7.45 with NaOH). Patch-pipettes were fire-polished to 2.5–4 MΩ. The pipette dialysis solution for I<sub>hERG</sub> measurement contained (in mM): 130 KCl, 1 MgCl<sub>2</sub>, 5 EGTA, 5 MgATP, and 10 HEPES (titrated to pH of 7.2 with KOH). Dronedarone powder (Sequoia Research Products, Pangbourne, UK) was dissolved in ethanol to produce an initial stock solution of 50 mM, which was serially diluted to produce stock solutions ranging from 50 mM to 3 μM; these were diluted 1:1000 fold with Tyrode's solution to achieve the final superfusate drug concentrations stated in the ‘<xref rid="s0045" ref-type="sec">Results</xref>’.</p>
      </sec>
      <sec id="s0030">
        <label>2.4</label>
        <title>Experimental protocols and analysis</title>
        <p>Whole cell conventional and human action potential (AP) voltage clamp recordings of hERG current (I<sub>hERG</sub>) were made at 37 ± 1 °C as previously reported <xref rid="bb0165" ref-type="bibr">[33]</xref>. Data digitization rates were 10–25 kHz during all protocols and an appropriate bandwidth of 2–10 kHz was set on the amplifier. Note that L532P I<sub>hERG</sub> exhibited considerable cell-to-cell heterogeneity in amplitude, presumably due to variable transfection efficiency; consequently in a number of figures WT and L532 I<sub>hERG</sub> are displayed with different current scales (this is highlighted in the relevant figure legends). Statistical comparisons were made using a Student's <italic>t</italic>-test or two way analysis of variance (ANOVA) followed by Tukey post hoc test, as appropriate. <italic>P</italic> values of less than 0.05 were taken as being statistically significant.</p>
      </sec>
      <sec id="s0035">
        <label>2.5</label>
        <title>Concentration–response data correction for I<sub>hERG</sub> run-down</title>
        <p>As previously reported <xref rid="bb0145" ref-type="bibr">[29]</xref>, in this study dronedarone exhibited a progressive development of I<sub>hERG</sub> blockade, reaching a stable level of block by 10 min of drug exposure. During this period, there was some overlying run-down of I<sub>hERG</sub>. Therefore, control experiments were performed. For these, WT and L532P I<sub>hERG</sub> were monitored during a 2–4 min stabilization period by repeated use of the standard voltage ‘step’ protocol, followed by a 10 min recording period in normal Tyrode's solution. The mean level of run-down of WT I<sub>hERG</sub> tails over 10 min was 13.4 ± 1.6% of the peak tail magnitude (n = 6 cells) while for L532P I<sub>hERG</sub> tails this was 15.7 ± 2.5% (n = 6 cells). To correct concentration–response data for I<sub>hERG</sub> run-down, we subtracted 13.4% of WT or 15.7% of L532P current magnitude from the last tail current in the control periods and used the resulting value to calculate fractional block following (10 min) exposure to dronedarone.</p>
      </sec>
      <sec id="s0040">
        <label>2.6</label>
        <title>Homology modeling</title>
        <p>A full open-state homology model of the hERG membrane domain was constructed using the crystal structure of a Kv1.2/Kv2.1 paddle chimera (PDB ID: 2R9R) determined by Long et al <xref rid="bb0175" ref-type="bibr">[35]</xref>. The template was retrieved from the RCSB Protein Data Bank as a monomer. ClustalW2, TMPred and UNIPROT were used to perform the sequence alignment, which was refined manually with the help of literature regarding hERG and other Kv channels. Full details of the model will be described elsewhere; however the homology used to align the S4 sequence of hERG into the paddle chimera structure is shown in <xref rid="f0035" ref-type="fig">Fig. 7</xref>. Amino acid substitutions, including generation of the L532P mutation, were made using the Biopolymer function within InsightII (Accelrys), and the Protein Data Bank was used to search for suitable linker constructs including the extracellular turret region. The symmetry operator within the PDB file 2R9R was used to construct a homotetramer and hERG monomers were superimposed onto this to generate a tetrameric homology model of hERG. The final open channel hERG homology model and the L532P mutant were energy minimized using Discover 2.9.8 (Accelrys). The stereochemical quality of the structures was verified using PROCHECK <xref rid="bb0245" ref-type="bibr">[49]</xref>.</p>
      </sec>
    </sec>
    <sec id="s0045">
      <label>3</label>
      <title>Results</title>
      <sec id="s0050">
        <label>3.1</label>
        <title>Effects of the L532P mutation on I<sub>hERG</sub> profiles during a standard voltage ‘step’ protocol</title>
        <p><xref rid="f0005" ref-type="fig">Fig. 1</xref>B shows profiles of WT and L532P I<sub>hERG</sub> elicited by a protocol composed of depolarizing voltage commands from − 80 to + 20 mV and a repolarizing step to − 40 mV. WT I<sub>hERG</sub> (<xref rid="f0005" ref-type="fig">Fig. 1</xref>Bi) exhibited well-established characteristics: current development during the applied depolarization, with a larger I<sub>hERG</sub> ‘tail’ elicited during a repolarizing step to − 40 mV (end pulse current was 0.48 ± 0.04 fold that of tail current amplitude; n = 14 cells). By contrast L532P I<sub>hERG</sub> increased rapidly on step-depolarization, with current during the + 20 mV step that was much larger than the I<sub>hERG</sub> tail on repolarization to − 40 mV (<xref rid="f0005" ref-type="fig">Fig. 1</xref>Bii; end pulse current amplitude was 1.45 ± 0.09 fold that of tail current amplitude; n = 43 cells). Tail current decline was much faster for L532P than for WT I<sub>hERG</sub> (compare <xref rid="f0005" ref-type="fig">Fig. 1</xref>Bii (and inset) with <xref rid="f0005" ref-type="fig">Fig. 1</xref>Bi).</p>
        <p>The voltage-dependence of WT and L532P I<sub>hERG</sub> was compared using 2 s depolarizing voltage steps from − 80 mV to potentials between − 40 and + 60 mV. Representative traces are shown in <xref rid="f0010" ref-type="fig">Fig. 2</xref>A and B for WT and L532P hERG respectively. WT I<sub>hERG</sub> increased progressively with depolarization up to ~ 0 mV, declining at more positive potentials, giving rise to marked negative slope in the current–voltage (I–V) relation (<xref rid="f0010" ref-type="fig">Fig. 2</xref>A, C). Proportionately greater L532P than WT I<sub>hERG</sub> was elicited by depolarization to − 40 and − 30 mV, but then smaller increases in current were seen with progressive depolarization up to 0–+10 mV (<xref rid="f0010" ref-type="fig">Fig. 2</xref>B, C). Rectification of L532P I<sub>hERG</sub> was evident at positive voltages. The normalized mean I–V data shown in <xref rid="f0010" ref-type="fig">Fig. 2</xref>C show the more gradual increase in L532P than WT I<sub>hERG</sub> up to ~ 0–+10 mV and positively shifted rectification of the end pulse I–V relationship. Normalized I–V relations for I<sub>hERG</sub> tail currents were used to compare voltage dependent activation of the two channels, with Boltzmann fitting used to derive half-maximal activation voltage (V<sub>0.5</sub>) and slope (<italic>k</italic>) values. At − 40 mV there was significantly greater L532P I<sub>hERG</sub> activation than for WT-hERG; however at potentials between − 20 mV and ~+30 mV, activation was significantly less extensive for mutant than WT channels, with a shallower slope of the activation relationship (<xref rid="f0010" ref-type="fig">Fig. 2</xref>D). Derived V<sub>0.5</sub> and <italic>k</italic> values for WT I<sub>hERG</sub> were − 16.6 ± 2.3 mV and 6.8 ± 0.3 mV (n = 7), while for L532P these were + 19.2 ± 2.8 mV and 12.4 ± 0.9 mV (n = 9, <italic>P</italic> &lt; 0.001 for both V<sub>0.5</sub> and <italic>k</italic> versus WT). Thus, L532P hERG showed greater activation than WT I<sub>hERG</sub> but an ~+ 36 mV shift in activation V<sub>0.5</sub> compared to the WT channel.</p>
      </sec>
      <sec id="s0055">
        <label>3.2</label>
        <title>Effects of the L532P mutation on the fully activated I–V relation and on deactivation and activation time-courses</title>
        <p>The protocol used to elicit the fully activated I–V relation and quantify deactivation (identical to that used previously in <xref rid="bb0065 bb0155" ref-type="bibr">[13,31]</xref>) is shown in <xref rid="f0015" ref-type="fig">Fig. 3</xref>Aii, with representative current traces for WT I<sub>hERG</sub> in <xref rid="f0015" ref-type="fig">Fig. 3</xref>Ai and for L532P I<sub>hERG</sub> in <xref rid="f0015" ref-type="fig">Fig. 3</xref>B. For both channels, the peak current on the repolarizing steps to different voltages was normalized to the maximal observed peak current during the protocol and plotted against voltage <xref rid="bb0065 bb0155" ref-type="bibr">[13,31]</xref>, see <xref rid="f0015" ref-type="fig">Fig. 3</xref>C. For WT I<sub>hERG</sub>, the fully activated I–V relation was maximal for the repolarizing step to ~−30 mV, whereas for L532P I<sub>hERG</sub> this was positively shifted. The WT hERG fully activated I–V relation reversed at − 84.3 ± 0.9 mV (n = 6), whereas the comparable value for L532P was − 80.3 ± 0.8 mV (n = 9; <italic>P</italic> &lt; 0.005). The deactivating component of I<sub>tails</sub> at each repolarization step was fitted with a bi-exponential function to derive fast and slow (τ<sub>f</sub> and τ<sub>s</sub>) time constants of deactivation (plotted in <xref rid="f0015" ref-type="fig">Fig. 3</xref>D and E). Both τ<sub>f</sub> and τ<sub>s</sub> values were significantly smaller for L532P I<sub>hERG</sub> than for WT I<sub>hERG</sub> at repolarization potentials of -60 mV and more positive. There were also significant differences between WT and L532P hERG at most membrane potentials examined for the fraction of deactivation described by τ<sub>f</sub> (<xref rid="f0015" ref-type="fig">Fig. 3</xref>F). An additional observation was that, while bi-exponential fits to deactivating WT I<sub>hERG</sub> tails yielded little residual unfitted current at negative voltages (for example, residual unfitted components of only 3.4 ± 1.0% and 3.2 ± 0.8% of peak tail current were obtained respectively at − 60 and − 70 mV), for L532P substantial residual current remained. Thus at − 60 mV residual unfitted current for L532P I<sub>hERG</sub> was 23.4 ± 4.9% of peak tail current (<italic>P</italic> &lt; 0.01 compared to WT), although at − 70 mV the greater residual I<sub>hERG</sub> for L532P-hERG (12.4 ± 4.6% of peak tail current) did not attain statistically significant difference from WT hERG (<italic>P</italic> &gt; 0.05). The presence of residual current is consistent with greater current activation at some negative voltages for L532P hERG (see also <xref rid="f0010" ref-type="fig">Fig. 2</xref>D), though perhaps not with complete destabilization of closed channel state(s). An envelope of tails protocol (inset of <xref rid="f0015" ref-type="fig">Fig. 3</xref>G; see also <xref rid="bb0165" ref-type="bibr">[33]</xref>) was used to compare time-dependence of activation of I<sub>hERG</sub> between the two channels at + 20 mV. Mono-exponential fitting of mean normalized tail currents elicited by the protocol (<xref rid="f0015" ref-type="fig">Fig. 3</xref>G) yielded for WT I<sub>hERG</sub> a τ<sub>act</sub> of 67.9 ± 6.1 ms (n = 9) and of 32.6 ± 2.2 ms for L532P I<sub>hERG</sub> (n = 6, <italic>P</italic> &lt; 0.001). Additional analysis of pulse currents elicited by the I–V protocol shown in <xref rid="f0010" ref-type="fig">Fig. 2</xref>A, B between − 40 and 0 mV yielded significantly reduced values for time to half-maximal current (t<sub>half</sub>) at each potential for L532P (at -30 mV t<sub>half</sub> was 30 ± 10 ms for L532P I<sub>hERG</sub> compared to 490 ± 30 ms for WT I<sub>hERG</sub>, <italic>P</italic> &lt; 0.001; while at 0 mV the respective values were 10 ± 2 ms and 130 ± 40 ms, <italic>P</italic> &lt; 0.01). Collectively, these results indicate that, over a range of potentials, L532P I<sub>hERG</sub> both activated and deactivated faster than did WT I<sub>hERG</sub></p>
      </sec>
      <sec id="s0060">
        <label>3.3</label>
        <title>Effects of the L532P mutation on voltage and time dependence of inactivation</title>
        <p>The voltage-dependence of WT I<sub>hERG</sub> inactivation (availability) was assessed using the protocol shown in <xref rid="f0020" ref-type="fig">Fig. 4</xref>A (and lower trace in 4 C): an initial step to + 40 mV activated and then inactivated I<sub>hERG</sub>; a ‘ladder’ of brief (2 ms) repolarizing steps to a range of potentials (to relieve inactivation to varying extents) was followed by a third step to + 40 mV. The magnitude of peak current elicited by the third step reflected the extent of availability induced by the second step. Representative WT I<sub>hERG</sub> records are shown in <xref rid="f0020" ref-type="fig">Fig. 4</xref>C. In order to correct for possible deactivation during this protocol, as in previous work from our laboratory <xref rid="bb0065" ref-type="bibr">[13]</xref>, a method described by Zou et al <xref rid="bb0260" ref-type="bibr">[52]</xref> was used: peak current amplitudes during the third pulse were obtained by single exponential fitting of the currents and extrapolation to the start of the third step. Peak currents during the third step were then normalized to maximal current and mean data were plotted as shown in <xref rid="f0020" ref-type="fig">Fig. 4</xref>E. Boltzmann fitting this relation yielded an inactivation V<sub>0.5</sub> value of − 70.3 ± 1.7 mV (<italic>k</italic> = 19.6 ± 0.5 mV; n = 9). As rectification of the I–V relation for L532P I<sub>hERG</sub> in <xref rid="f0010" ref-type="fig">Fig. 2</xref>C was positively shifted, in order to ensure adequate inactivation during the availability protocol, the protocol was modified so that the first and third step potential was set to + 80 mV (<xref rid="f0020" ref-type="fig">Fig. 4</xref>B, lower trace in 4D; see <xref rid="bb0065" ref-type="bibr">[13]</xref>). Representative traces are shown in <xref rid="f0020" ref-type="fig">Fig. 4</xref>D with mean normalized data shown in <xref rid="f0020" ref-type="fig">Fig. 4</xref>E. Boltzmann-fitting of this plot gave an inactivation V<sub>0.5</sub> for L532P I<sub>hERG</sub> of − 38.7 ± 3.7 mV (<italic>k</italic> = 28.7 ± 2.8 mV, n = 6, <italic>P</italic> &lt; 0.0001 for V<sub>0.5</sub> and <italic>P</italic> &lt; 0.005 for <italic>k</italic> value compared with WT). Calculation of the steady-state activation-inactivation parameter product (“window current”) across a wide range of voltages (− 80 mV to + 60 mV) for WT and L532P I<sub>hERG</sub> indicated slightly greater window current for L532P than WT I<sub>hERG</sub> at potentials negative to approximately -50 mV and much greater window current for L532P hERG positive to approximately − 5 mV (data not shown). The currents elicited following the repolarizing step to -140 mV were also used to quantify the time-course of development of inactivation (from a single-exponential fit) for the two channels; the τ-values obtained for WT and L532P I<sub>hERG</sub> were 1.34 ± 0.13 ms and 1.0 ± 0.06 ms respectively (<italic>P</italic> &gt; 0.05). The rate of recovery from inactivation was assessed using the protocol shown in the inset of <xref rid="f0020" ref-type="fig">Fig. 4</xref>F and see <xref rid="bb0070 bb0170" ref-type="bibr">[14,34]</xref>. Normalized peak outward transient currents were plotted against the duration of the repolarization step and fitted with a mono-exponential function, giving τ values of 1.92 ± 0.07 ms for WT (n = 10) and of 1.43 ± 0.12 ms for L532P (n = 11) (<italic>P</italic> &lt; 0.005). It should be noted that the greatly accelerated deactivation for L532P meant that after the first 2–3 current transients, the amplitude of successive transients declined. To highlight this, the plot in <xref rid="f0020" ref-type="fig">Fig. 4</xref>F also shows consecutive points for L532P joined by dotted straight lines. Collectively, the data shown in <xref rid="f0020" ref-type="fig">Fig. 4</xref> indicate that the voltage-dependence of I<sub>hERG</sub> inactivation was positively shifted (a V<sub>0.5</sub> shift of + 32 mV), with a modest acceleration in recovery of inactivation.</p>
        <p><xref rid="t0005" ref-type="table">Table 1</xref> summarizes the biophysical parameters obtained for WT and L532P I<sub>hERG</sub></p>
      </sec>
      <sec id="s0065">
        <label>3.4</label>
        <title>L532P I<sub>hERG</sub> profile during ventricular AP clamp</title>
        <p>An example trace of WT I<sub>hERG</sub> during the course of an imposed ventricular AP waveform is shown in <xref rid="f0025" ref-type="fig">Fig. 5</xref>Ai, while <xref rid="f0025" ref-type="fig">Fig. 5</xref>Aii shows a comparable trace for L532P I<sub>hERG</sub> (black trace, with the WT current from <xref rid="f0025" ref-type="fig">Fig. 5</xref>Ai also overlaid (gray trace) for comparison). WT I<sub>hERG</sub> increased progressively through the AP plateau phase, before declining during terminal AP repolarization (<xref rid="f0025" ref-type="fig">Fig. 5</xref>Ai and see <xref rid="bb0065 bb0155 bb0165" ref-type="bibr">[13,31,33]</xref>). By contrast, L532P I<sub>hERG</sub> increased much earlier during the AP command, peaking earlier during the AP plateau phase, with a ‘domed’ or ‘inverted U’ shaped profile and more rapid decline than the WT current during the terminal AP phase (<xref rid="f0025" ref-type="fig">Fig. 5</xref>Aii). <xref rid="f0025" ref-type="fig">Fig. 5</xref>B shows the mean normalized instantaneous I–V relation for WT I<sub>hERG</sub> during AP repolarization, with maximal current relatively late in repolarization (at − 30.7 ± 2.1 mV; n = 7 cells). <xref rid="f0025" ref-type="fig">Fig. 5</xref>C shows the mean instantaneous I–V relation for L532P I<sub>hERG</sub>, with current rising to a maximal value at + 15.7 ± 2.4 mV (n = 8; <italic>P</italic> &lt; 0.0001 versus WT) early in repolarization, then declining linearly with repolarization voltage</p>
      </sec>
      <sec id="s0070">
        <label>3.5</label>
        <title>Modulation by L532P of pharmacological inhibition of I<sub>hERG</sub> by dronedarone</title>
        <p>Further experiments were performed in which effects were assessed of the L532P mutation on pharmacological inhibition of I<sub>hERG</sub>. For these experiments, the Class III antiarrhythmic agent dronedarone (Droned) was chosen; this drug is a non-iodinated analog of amiodarone that exhibits hERG inhibition involving interaction with both activated and inactivated channels <xref rid="bb0145" ref-type="bibr">[29]</xref>. The voltage protocol used was composed of a 2 s voltage command to + 20 mV, followed by repolarization to − 40 mV to observe I<sub>hERG</sub> tails. It also incorporated a brief (50 ms) pre-pulse from − 80 to − 40 mV prior to the test command, in order to quantify the instantaneous current at − 40 mV. Comparison between this instantaneous current and the peak outward I<sub>hERG</sub> tail amplitude on repolarization to − 40 mV facilitated accurate measurement of WT I<sub>hERG</sub> tail amplitude (cf <xref rid="bb0150 bb0265" ref-type="bibr">[30,53]</xref>). For consistency the same protocol was applied in experiments on both WT and L532P I<sub>hERG</sub>. <xref rid="f0030" ref-type="fig">Fig. 6</xref>A shows effects of 300 nM dronedarone on WT I<sub>hERG</sub> while <xref rid="f0030" ref-type="fig">Fig. 6</xref>B shows comparable data for L532P I<sub>hERG</sub>; current inhibition by the drug was more extensive for the WT than the mutant channel. <xref rid="f0030" ref-type="fig">Fig. 6</xref>C shows mean (run-down corrected) data for a range of drug concentrations, in which fractional block at each concentration plotted against the Log [Dronedarone] concentration. The data were fitted with a Hill equation and the derived IC<sub>50</sub> and Hill co-efficient were 42.6 ± 3.4 nM and 0.9 ± 0.1 for WT hERG, and 227.0 ± 38.6 nM and 1.0 ± 0.2 for L532P hERG. Thus the L532P mutation resulted in a 5.3-fold rightward shift in the IC<sub>50</sub> for I<sub>hERG</sub> block by dronedarone (<italic>P</italic> &lt; 0.005 for WT and mutant IC<sub>50</sub> values).</p>
      </sec>
      <sec id="s0075">
        <label>3.6</label>
        <title>Homology modeling</title>
        <p>In the absence of direct structural information from crystal structures of (h)ERG channels, homology modeling offers a useful way of investigating potential structural context(s) for changes to hERG channel function. Therefore, we adopted homology modeling based on a Kv1.2/2.1 template, in order to explore the structural context of the L532P mutation. The L532 residue resides in the helical S4 transmembrane segment, composed of ~ 20 amino acids as indicated by homology with eukaryotic voltage-gated channels of known structure (e.g. <xref rid="bb0225 bb0250" ref-type="bibr">[45] and [50]</xref>). As shown in <xref rid="f0005" ref-type="fig">Fig. 1</xref>A, the amino acid sequence in this region is highly conserved, with positively charged residues (arginines or lysines) regularly separated by two hydrophobic residues. The hydrophobic leucine at residue 532 is located after the second arginine (R531) in the C-terminal half of S4 (<xref rid="f0005" ref-type="fig">Figs. 1</xref>A, <xref rid="f0035" ref-type="fig">7</xref>A). The alignment of S4 (and adjacent sequence) between hERG and the Kv1.2/2.1 ‘paddle chimera’ channel reported by Long et al <xref rid="bb0175" ref-type="bibr">[35]</xref>, is shown in <xref rid="f0035" ref-type="fig">Fig. 7</xref>A. Homology modeling based on the paddle chimera (see <xref rid="s0010" ref-type="sec">Methods</xref>) places the L532 residue near the external face of the S4 helix where it lies close to the S5 helix of an adjacent subunit, at least in the open form of the channel model (<xref rid="f0035" ref-type="fig">Fig. 7</xref>B).</p>
      </sec>
    </sec>
    <sec id="s0080">
      <label>4</label>
      <title>Discussion</title>
      <sec id="s0085">
        <label>4.1</label>
        <title>Summary of principal findings</title>
        <p>Although some characteristics of L532P I<sub>hERG</sub> have been recorded at ambient temperature from channels expressed in <italic>Xenopus</italic> oocytes <xref rid="bb0125" ref-type="bibr">[25]</xref>, to our knowledge there are no prior reports of similar data for mammalian cell hERG expression at 37 °C. Moreover, no information has hitherto been published on the effects of the L532P hERG mutation on time-dependent activation/inactivation kinetics of I<sub>hERG</sub> or upon channel structure. Our data are in agreement with results obtained previously from <italic>Xenopus</italic> oocytes <xref rid="bb0125" ref-type="bibr">[25]</xref>, in indicating a low activation threshold for L532P compared to WT I<sub>hERG</sub>, with an accompanying shift in activation V<sub>0.5</sub> of ~+36 mV here compared to ~+41 mV in <italic>Xenopus</italic> oocytes <xref rid="bb0125" ref-type="bibr">[25]</xref>. However, a marked (~+50 mV) shift in voltage-dependent inactivation of L532P I<sub>hERG</sub> from <italic>Xenopus</italic> oocytes was reported, whereas, under our experimental conditions the inactivation-shift produced by the mutation was somewhat less extensive (~+30 mV shift in V<sub>0.5</sub>). In addition to these effects of the mutation on voltage-dependent kinetics of I<sub>hERG</sub>, we also observed faster I<sub>hERG</sub> activation (and deactivation) and faster recovery from inactivation for L532P I<sub>hERG</sub>. This combination of alterations results in a markedly altered current profile under AP voltage clamp (<xref rid="f0025" ref-type="fig">Fig. 5</xref>). We also provide the first demonstration that this S4 mutation, which is located in a region distinct from the S6 and inner helices that comprise the canonical drug binding site on hERG <xref rid="bb0010 bb0180" ref-type="bibr">[2,36]</xref>, has the potential to modify potency of drug block of I<sub>hERG</sub>.</p>
      </sec>
      <sec id="s0090">
        <label>4.2</label>
        <title>The L532P mutation in the context of S4 involvement in hERG channel gating</title>
        <p>The hERG channel is distinguished by its rapid inactivation gating and comparatively slow activation gating. It is generally believed that slow activation of hERG starts from outward translation of the positive charged residues in S4 voltage sensor across the membrane field upon changes in membrane potential, which in turn causes opening of an activation gate involving S6 domains <xref rid="bb0140 bb0185 bb0205" ref-type="bibr">[28,37,41]</xref>. The S4–S5 linker has been suggested to couple directly S4 movement to the activation gate in hERG <xref rid="bb0190 bb0195" ref-type="bibr">[38,39]</xref>. Alanine scanning mutagenesis and homology modeling have suggested a spiral pattern on the S4 domain of residues mutations to which perturb activation, with inactivation-perturbing mutation positions mapped to a distinct face of the S4 helix <xref rid="bb0190 bb0225" ref-type="bibr">[38,45]</xref>. Positively charged residues K525, R528 and K538 in S4 have been suggested to be those most important for activation of the channel, with residues R528 and R531 as key candidates for binding to residues in other transmembrane domains through salt bridges and with residue R531 implicated in stabilizing the open state <xref rid="bb0210 bb0215 bb0220" ref-type="bibr">[42–44]</xref>. Alanine substitution at L532 produced little perturbation of activation or inactivation <xref rid="bb0225" ref-type="bibr">[45]</xref>, whereas substitution with tryptophan (a bulkier hydrophobic residue) has been reported to accelerate deactivation rate, but to have comparatively little effect on activation rate <xref rid="bb0220" ref-type="bibr">[44]</xref>. The presence of proline residues in transmembrane helices of membrane proteins is well known to perturb helical structure <xref rid="bb0230" ref-type="bibr">[46]</xref>. Given this and the key role identified for residue R531 in activation gating, it is perhaps unsurprising that proline substitution at the adjacent L532 residue significantly alters I<sub>hERG</sub> activation characteristics as it can be anticipated to alter S4 structure and influence of this domain on the S4–S5 linker. It has also been proposed that depolarization-induced motions in the S4 domain can change the orientation of 583–597 helix in the S5-P linker region of the channel or push it toward the pore, thereby facilitating I<sub>hERG</sub> inactivation. Upon membrane repolarization, a reversal of the above S4 movements would occur <xref rid="bb0235" ref-type="bibr">[47]</xref>. Perturbation of the S4 helix by proline could influence such interactions and the modest but statistically significant shift in I<sub>hERG</sub> reversal potential with the L532P-hERG is consistent with an allosteric effect of the mutation on the channel's selectivity filter (the + 4 mV shift in observed I<sub>hERG</sub> reversal potential is consistent with a decrease in K<sup>+</sup> over Na<sup>+</sup> ion selectivity; equivalent to a <italic>P</italic><sub>Na</sub>/<italic>P</italic><sub>K</sub> ratio of ~ 1.6-fold that for WT hERG). Our homology modeling raises an additional possibility for the influence of the L532P mutation on channel gating and drug binding to side chains that line the permeation pathway (e.g. residues on S6). In the context of the model (<xref rid="f0035" ref-type="fig">Fig. 7</xref>B) residue L532 lies closely apposed to the S5 domain (lying opposite residues W568 and Y569 of the S5 domain of an adjacent hERG subunit, with a minimal distance between atoms of the apposing residues of ~ 3.5 Å). This raises the possibility of S4–S5 interactions that would be anticipated to differ between L532- and P532-containing channels; these might be transmitted to the S6 helix through the intimate interactions between S5 and S6 <xref rid="bb0255" ref-type="bibr">[51]</xref>. Given the comparative lack of effect of alanine substitution at L532 on activation/inactivation <xref rid="bb0225" ref-type="bibr">[45]</xref>, one might speculate that, if present, these interactions become significant when a proline side chain is present in this residue. Further targeted mutagenesis work would be required to explore this possibility in greater depth.</p>
      </sec>
      <sec id="s0095">
        <label>4.3</label>
        <title>Phenotype comparison with the N588K and T618I gain-of-function mutations</title>
        <p>Under conditions comparable to those used in the present study, a previous investigation reported a marked (~+60 mV) voltage-shift in N588K I<sub>hERG</sub> inactivation without any accompanying shift in activation <xref rid="bb0065" ref-type="bibr">[13]</xref>. The recently discovered T618I mutation has been reported to shift inactivation by ~+50 mV, with an additional ~−5 mV shift in activation. Thus, both of these human SQTS hERG mutations produce greater inactivation-shifts to that seen for L532P in the present study. There are no AP clamp data currently available for T618I hERG, but direct comparison is possible between our AP clamp data for L532P I<sub>hERG</sub> and N588K I<sub>hERG</sub> studied under similar conditions <xref rid="bb0065 bb0070" ref-type="bibr">[13,14]</xref>. When elicited by a ventricular AP waveform similar to that used here, N588K I<sub>hERG</sub> exhibited a similar dome-shaped current, with maximal current during repolarization occurring &gt; 60 mV positive to that for WT I<sub>hERG</sub><xref rid="bb0070" ref-type="bibr">[14]</xref>. Simulation data indicate that the altered timing and magnitude of repolarizing I<sub>Kr</sub> in the setting of the SQT1 N588K mutation leads to marked ventricular AP abbreviation <xref rid="bb0085 bb0090 bb0095" ref-type="bibr">[17–19]</xref>. The AP abbreviation with N588K is also associated with flattening of the AP duration–restitution curve <xref rid="bb0090" ref-type="bibr">[18]</xref> and the overall effects of this mutation are likely to facilitate susceptibility to re-entrant arrhythmia. Despite differences from N588K-hERG in the overall effects on I<sub>hERG</sub> kinetics of the L532P mutation, it resulted in a remarkably similar dome-shaped I<sub>hERG</sub> profile under AP clamp to that seen for N588K-hERG, with an ~+47 mV shift in maximal outward current during repolarization. This is consistent with the previously advanced notion based on in silico modeling that kinetic changes produced by the L532P-hERG mutation could, in principle, lead to ventricular AP abbreviation <xref rid="bb0125" ref-type="bibr">[25]</xref>. In addition, the normally slow deactivation of I<sub>Kr</sub>/I<sub>hERG</sub> means that the underlying channels are able to conduct current for a period following completion of AP repolarization, which may normally confer some protection against premature depolarization <xref rid="bb0070 bb0170 bb0240" ref-type="bibr">[14,34,48]</xref>. Consistent with this, our AP clamp comparison of WT and L532P I<sub>hERG</sub> (<xref rid="f0025" ref-type="fig">Fig. 5</xref>Aii) shows clearly that WT I<sub>hERG</sub> had not yet returned fully to baseline immediately following completion of AP repolarization. By contrast, the overlain L532P current declines more extensively during this time (<xref rid="f0025" ref-type="fig">Fig. 5</xref>Aii) The marked acceleration of deactivation present for L532P-hERG might therefore be anticipated to impair the potentially protective effect of hERG and, if the mutation were to present clinically, this would likely increase ventricular susceptibility to premature excitation (although increased susceptibility to the effect of small magnitude premature depolarizations may be mitigated to some extent by the slight increase in window I<sub>hERG</sub> negative to ~−50 mV). As accelerated deactivation is a feature which is shared with L499P-zERG <xref rid="bb0125" ref-type="bibr">[25]</xref>, it could have contributed to the increased arrhythmia susceptibility of <italic>reg</italic> mutant zebrafish <xref rid="bb0125" ref-type="bibr">[25]</xref>.</p>
        <p>The N588K-hERG mutation is well-established to attenuate markedly the inhibitory actions of Class III but not Class Ia antiarrhythmic drugs (which depend less than do Class III I<sub>Kr</sub>-selective drugs on channel inactivation to bind) <xref rid="bb0050 bb0075 bb0080" ref-type="bibr">[10,15,16]</xref>. The T618I hERG mutation has been reported largely to retain sensitivity to inhibition by high concentrations of quinidine and sotalol, though full concentration–response data are not available <xref rid="bb0160" ref-type="bibr">[32]</xref>. The Class III agent dronedarone inhibits WT I<sub>hERG</sub> in a manner that indicates contingency on channel gating, with little preference for activated over inactivated channel states <xref rid="bb0145" ref-type="bibr">[29]</xref>. The compound exhibits reduced I<sub>hERG</sub> blocking potency under conditions of substantial inward [K<sup>+</sup>] flux, which is suggestive of drug binding in or close to the ion conduction pathway <xref rid="bb0145" ref-type="bibr">[29]</xref>; docking analysis indicates that the compound can bind within the channel's inner cavity <xref rid="bb0200" ref-type="bibr">[40]</xref>. Considering this together with the location of the S4 domain relative to the inner cavity, it is unlikely that the L532 residue interacts directly with dronedarone. Rather, it is more likely that altered L532P-hERG channel gating impairs the ability of the drug to interact with its binding site. In this regard it is notable that the ~ 5-fold increase in IC<sub>50</sub> for dronedarone seen here is similar to that (~ 4.2-fold) reported for structurally-related amiodarone with the N588K hERG mutation <xref rid="bb0150" ref-type="bibr">[30]</xref>. Indeed, the distinct location in the hERG channel of the N588, T618 and L532 residues, together with distinct kinetic effects of the N588K and L532P mutations under voltage clamp with similarities under AP clamp, makes the L532P mutant an attractive comparator for future pharmacological study targeted toward identifying consensus inhibitors of different known gain-of-function hERG mutants.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="bb0005">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tamargo</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Caballero</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Gόmez</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Valenzuela</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Delpόn</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Pharmacology of cardiac potassium channels</article-title>
          <source>Cardiovasc. Res.</source>
          <volume>62</volume>
          <year>2004</year>
          <fpage>9</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="pmid">15023549</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0010">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hancox</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>McPate</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>El Harchi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y.H.</given-names>
            </name>
          </person-group>
          <article-title>The hERG potassium channel and hERG screening for drug-induced torsades de pointes</article-title>
          <source>Pharmacol. Ther.</source>
          <volume>119</volume>
          <year>2008</year>
          <fpage>118</fpage>
          <lpage>132</lpage>
          <pub-id pub-id-type="pmid">18616963</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0015">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sanguinetti</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Curran</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Keating</surname>
              <given-names>M.T.</given-names>
            </name>
          </person-group>
          <article-title>A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the I<sub>Kr</sub> potassium channel</article-title>
          <source>Cell</source>
          <volume>81</volume>
          <year>1995</year>
          <fpage>299</fpage>
          <lpage>307</lpage>
          <pub-id pub-id-type="pmid">7736582</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0020">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Trudeau</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Warmke</surname>
              <given-names>J.W.</given-names>
            </name>
            <name>
              <surname>Ganetzky</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Robertson</surname>
              <given-names>G.A.</given-names>
            </name>
          </person-group>
          <article-title>HERG, an inward rectifier in the voltage-gated potassium channel family</article-title>
          <source>Science</source>
          <volume>269</volume>
          <year>1995</year>
          <fpage>92</fpage>
          <lpage>95</lpage>
          <pub-id pub-id-type="pmid">7604285</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0025">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Modell</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Lehmann</surname>
              <given-names>M.H.</given-names>
            </name>
          </person-group>
          <article-title>The long QT syndrome family of cardiac ion channelopathies: a HuGE review</article-title>
          <source>Genet. Med.</source>
          <volume>8</volume>
          <year>2006</year>
          <fpage>143</fpage>
          <lpage>155</lpage>
          <pub-id pub-id-type="pmid">16540748</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0030">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sanguinetti</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Tristani-Firouzi</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>hERG potassium channels and cardiac arrhythmia</article-title>
          <source>Nature</source>
          <volume>440</volume>
          <year>2006</year>
          <fpage>463</fpage>
          <lpage>469</lpage>
          <pub-id pub-id-type="pmid">16554806</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0035">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Perry</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sanguinetti</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Mitcheson</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Revealing the structural basis of action of hERG potassium channel activators and blockers</article-title>
          <source>J. Physiol.</source>
          <volume>588</volume>
          <year>2010</year>
          <fpage>3157</fpage>
          <lpage>3167</lpage>
          <pub-id pub-id-type="pmid">20643767</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0040">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McPate</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Witchel</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Hancox</surname>
              <given-names>J.C.</given-names>
            </name>
          </person-group>
          <article-title>Short QT Syndrome</article-title>
          <source>Futur. Cardiol.</source>
          <volume>2</volume>
          <year>2006</year>
          <fpage>293</fpage>
          <lpage>301</lpage>
        </element-citation>
      </ref>
      <ref id="bb0045">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maury</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Extramiana</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Sbragia</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Giustetto</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Schimpf</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Duparc</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Wolpert</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Denjoy</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Delay</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Borgreffe</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Gaita</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>Short QT syndrome. Update on a recent entity</article-title>
          <source>Arch. Cardiovasc. Dis.</source>
          <volume>101</volume>
          <year>2008</year>
          <fpage>779</fpage>
          <lpage>786</lpage>
          <pub-id pub-id-type="pmid">19059573</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0050">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brugada</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Dumaine</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Cordeiro</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Gaita</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Borggrefe</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Menendez</surname>
              <given-names>T.M.</given-names>
            </name>
            <name>
              <surname>Brugada</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Pollevick</surname>
              <given-names>G.D.</given-names>
            </name>
            <name>
              <surname>Wolpert</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Burashnikov</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Matuso</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Y.S.</given-names>
            </name>
            <name>
              <surname>Guerchicoff</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bianchi</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Guistetto</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Schimpf</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Brugada</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Antzelevitch</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Sudden death associated with short-QT syndrome linked to mutations in HERG</article-title>
          <source>Circulation</source>
          <volume>109</volume>
          <year>2004</year>
          <fpage>30</fpage>
          <lpage>35</lpage>
          <pub-id pub-id-type="pmid">14676148</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0055">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hong</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Bjeerregaard</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Gussak</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Brugada</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Short QT syndrome and atrial fibrillation caused by mutation in KCNH2</article-title>
          <source>J. Cardiovasc. Electophysiol.</source>
          <volume>16</volume>
          <year>2005</year>
          <fpage>394</fpage>
          <lpage>396</lpage>
        </element-citation>
      </ref>
      <ref id="bb0060">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cordeiro</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Brugada</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Y.S.</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Dumaine</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Modulation of I<sub>Kr</sub> inactivation by mutation N588K in KCNH2: a link to arrhythmogenesis in short QT syndrome</article-title>
          <source>Cardiovasc. Res.</source>
          <volume>67</volume>
          <year>2005</year>
          <fpage>498</fpage>
          <lpage>509</lpage>
          <pub-id pub-id-type="pmid">16039272</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0065">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McPate</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Duncan</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>Milnes</surname>
              <given-names>J.T.</given-names>
            </name>
            <name>
              <surname>Witchel</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Hancox</surname>
              <given-names>J.C.</given-names>
            </name>
          </person-group>
          <article-title>The N588K-HERG K<sup>+</sup> channel mutation in the ‘short QT syndrome’: mechanism of gain-in-function determined at 37 °C</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <volume>334</volume>
          <year>2005</year>
          <fpage>441</fpage>
          <lpage>449</lpage>
          <pub-id pub-id-type="pmid">16011830</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0070">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McPate</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Ideniran</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Cordeiro</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Witchel</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Hancox</surname>
              <given-names>J.C.</given-names>
            </name>
          </person-group>
          <article-title>Comparative effects of the short QT N588K mutation at 37 °C on hERG K<sup>+</sup> channel current during ventricular, Purkinje fibre and atrial action potentials: an action potential clamp study</article-title>
          <source>J. Physiol. Pharmacol.</source>
          <volume>60</volume>
          <year>2009</year>
          <fpage>23</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="pmid">19439805</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0075">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wolpert</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Schimpf</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Giustetto</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Antzelevitch</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Cordeiro</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Dumaine</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Brugada</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Bauersfeld</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Gaita</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Borgreffe</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG</article-title>
          <source>J. Cardiovasc. Electophysiol.</source>
          <volume>16</volume>
          <year>2005</year>
          <fpage>54</fpage>
          <lpage>58</lpage>
        </element-citation>
      </ref>
      <ref id="bb0080">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McPate</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Duncan</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>Witchel</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Hancox</surname>
              <given-names>J.C.</given-names>
            </name>
          </person-group>
          <article-title>Disopyramide is an effective inhibitor of mutant HERG K<sup>+</sup> channels involved in variant 1 short QT syndrome</article-title>
          <source>J. Mol. Cell. Cardiol.</source>
          <volume>41</volume>
          <year>2006</year>
          <fpage>563</fpage>
          <lpage>566</lpage>
          <pub-id pub-id-type="pmid">16842817</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0085">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Hancox</surname>
              <given-names>J.C.</given-names>
            </name>
          </person-group>
          <article-title>In silico study of action potential and QT interval shortening due to loss of inactivation of the cardiac rapid delayed rectifier potassium current</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <volume>17</volume>
          <year>2004</year>
          <fpage>693</fpage>
          <lpage>699</lpage>
          <pub-id pub-id-type="pmid">15325285</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0090">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Priori</surname>
              <given-names>S.G.</given-names>
            </name>
            <name>
              <surname>Pandit</surname>
              <given-names>S.V.</given-names>
            </name>
            <name>
              <surname>Rivolta</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Berenfeld</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Ronchetti</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Dhamoon</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Napolitano</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Anumonwo</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>di Barletta</surname>
              <given-names>M.R.</given-names>
            </name>
            <name>
              <surname>Gudapakkam</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Bosi</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Stramba-Badiale</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Jalife</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene</article-title>
          <source>Circ. Res.</source>
          <volume>96</volume>
          <year>2005</year>
          <fpage>800</fpage>
          <lpage>807</lpage>
          <pub-id pub-id-type="pmid">15761194</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0095">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weiss</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Seemann</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Sachse</surname>
              <given-names>F.B.</given-names>
            </name>
            <name>
              <surname>Dossel</surname>
              <given-names>O.</given-names>
            </name>
          </person-group>
          <article-title>Modelling of short QT syndrome in a heterogeneous model of the human ventricular wall</article-title>
          <source>Europace</source>
          <volume>7</volume>
          <year>2005</year>
          <fpage>105</fpage>
          <lpage>117</lpage>
          <pub-id pub-id-type="pmid">16102508</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0100">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Itoh</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Horie</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Imoto</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Arrhythmogenesis in the short-QT syndrome associated with combined HERG channel gating defects: a simulation study</article-title>
          <source>Circ. J.</source>
          <volume>70</volume>
          <year>2006</year>
          <fpage>502</fpage>
          <lpage>508</lpage>
          <pub-id pub-id-type="pmid">16565572</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0105">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Extramiana</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Antzelevitch</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Amplified transmural dispersion of repolarization as the basis for arrhythmogenesis in a canine ventricular-wedge model of short-QT syndrome</article-title>
          <source>Circulation</source>
          <volume>110</volume>
          <year>2004</year>
          <fpage>3661</fpage>
          <lpage>3666</lpage>
          <pub-id pub-id-type="pmid">15569843</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0110">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Patel</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Antzelevitch</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Cellular basis for arrhythmogenesis in an experimental model of the SQT1 form of the short QT syndrome</article-title>
          <source>Hear. Rhythm.</source>
          <volume>5</volume>
          <year>2008</year>
          <fpage>585</fpage>
          <lpage>590</lpage>
        </element-citation>
      </ref>
      <ref id="bb0115">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Milberg</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Tegelkamp</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Osada</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Schimpf</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Wolpert</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Breithardt</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Borgreffe</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Eckardt</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome</article-title>
          <source>J. Cardiovasc. Electrophysiol.</source>
          <volume>18</volume>
          <year>2007</year>
          <fpage>658</fpage>
          <lpage>664</lpage>
          <pub-id pub-id-type="pmid">17521304</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0120">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nof</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Burashnikov</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Antzelevitch</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Cellular basis for atrial fibrillation in an experimental model of short QT1: implications for a pharmacological approach to therapy</article-title>
          <source>Hear. Rhythm.</source>
          <volume>7</volume>
          <year>2010</year>
          <fpage>251</fpage>
          <lpage>257</lpage>
        </element-citation>
      </ref>
      <ref id="bb0125">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hassel</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Scholz</surname>
              <given-names>E.P.</given-names>
            </name>
            <name>
              <surname>Trano</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Friedrich</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Just</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Meder</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Zitron</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Marquart</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Vogel</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Carle</surname>
              <given-names>C.A.</given-names>
            </name>
            <name>
              <surname>Seemann</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Fishman</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Katus</surname>
              <given-names>H.A.</given-names>
            </name>
            <name>
              <surname>Rottbauer</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>Deficient zebrafish ether-a-go-go-related gene channel gating causes short-QT syndrome in zebrafish reggae mutants</article-title>
          <source>Circulation</source>
          <volume>117</volume>
          <year>2008</year>
          <fpage>866</fpage>
          <lpage>875</lpage>
          <pub-id pub-id-type="pmid">18250272</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0130">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vandenberg</surname>
              <given-names>J.I.</given-names>
            </name>
            <name>
              <surname>Varghese</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Bursill</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Mahaut-Smith</surname>
              <given-names>M.P.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>C.L.</given-names>
            </name>
          </person-group>
          <article-title>Temperature dependence of human ether-a-go-go-related gene K<sup>+</sup> currents</article-title>
          <source>Am. J. Physiol. Cell. Physiol.</source>
          <volume>291</volume>
          <year>2006</year>
          <fpage>C165</fpage>
          <lpage>C175</lpage>
          <pub-id pub-id-type="pmid">16452156</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0135">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weerapura</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Nattel</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Chartier</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Caballero</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Hebert</surname>
              <given-names>T.F.</given-names>
            </name>
          </person-group>
          <article-title>A comparison of currents carried by HERG with and without the coexpression of MiRP1, and the native rapid delayed rectifier current. Is MiRP1 the missing link?</article-title>
          <source>J. Physiol.</source>
          <volume>540</volume>
          <year>2002</year>
          <fpage>15</fpage>
          <lpage>27</lpage>
          <pub-id pub-id-type="pmid">11927665</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0140">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Long</surname>
              <given-names>S.B.</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>E.B.</given-names>
            </name>
            <name>
              <surname>MacKinnon</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Voltage sensor of Kv1.2: structural basis of electromechanical coupling</article-title>
          <source>Science</source>
          <volume>309</volume>
          <year>2005</year>
          <fpage>903</fpage>
          <lpage>908</lpage>
          <pub-id pub-id-type="pmid">16002579</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0145">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ridley</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Milnes</surname>
              <given-names>J.T.</given-names>
            </name>
            <name>
              <surname>Witchel</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Hancox</surname>
              <given-names>J.C.</given-names>
            </name>
          </person-group>
          <article-title>High affinity HERG K<sup>+</sup> channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <volume>325</volume>
          <year>2004</year>
          <fpage>883</fpage>
          <lpage>891</lpage>
          <pub-id pub-id-type="pmid">15541373</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0150">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McPate</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Duncan</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>Hancox</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Witchel</surname>
              <given-names>H.J.</given-names>
            </name>
          </person-group>
          <article-title>Pharmacology of the short QT syndrome N588K-hERG K<sup>+</sup> channel mutation: differential impact on selected class I and class III antiarrhythmic drugs</article-title>
          <source>Br. J. Pharmacol.</source>
          <volume>155</volume>
          <year>2008</year>
          <fpage>957</fpage>
          <lpage>966</lpage>
          <pub-id pub-id-type="pmid">18724381</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0155">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hancox</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Levi</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Witchel</surname>
              <given-names>H.J.</given-names>
            </name>
          </person-group>
          <article-title>Time course and voltage dependence of expressed HERG current compared with native ‘rapid’ delayed rectifier K current during the cardiac ventricular action potential</article-title>
          <source>Pflugers Archiv.</source>
          <volume>436</volume>
          <year>1998</year>
          <fpage>843</fpage>
          <lpage>853</lpage>
          <pub-id pub-id-type="pmid">9799397</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0160">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sun</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Quan</surname>
              <given-names>X.Q.</given-names>
            </name>
            <name>
              <surname>Fromme</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Cox</surname>
              <given-names>R.H.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Kowey</surname>
              <given-names>P.R.</given-names>
            </name>
            <name>
              <surname>Yan</surname>
              <given-names>G.X.</given-names>
            </name>
          </person-group>
          <article-title>A novel mutation in the KCNH2 gene associated with short QT syndrome</article-title>
          <source>J. Mol. Cell. Cardiol.</source>
          <volume>50</volume>
          <year>2011</year>
          <fpage>433</fpage>
          <lpage>441</lpage>
          <pub-id pub-id-type="pmid">21130771</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0165">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>Y.H.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Alexeenko</surname>
              <given-names>V.A.</given-names>
            </name>
            <name>
              <surname>Dempsey</surname>
              <given-names>C.E.</given-names>
            </name>
            <name>
              <surname>Hancox</surname>
              <given-names>J.C.</given-names>
            </name>
          </person-group>
          <article-title>Characterization of recombinant hERG K<sup>+</sup> channel inhibition by the active metabolite of amiodarone desethyl-amiodarone</article-title>
          <source>J. Electrocardiol.</source>
          <volume>43</volume>
          <year>2010</year>
          <fpage>440</fpage>
          <lpage>448</lpage>
          <pub-id pub-id-type="pmid">20493497</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0170">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Du</surname>
              <given-names>C.Y.</given-names>
            </name>
            <name>
              <surname>Adeniran</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y.H.</given-names>
            </name>
            <name>
              <surname>El Harchi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>McPate</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Orchard</surname>
              <given-names>C.H.</given-names>
            </name>
            <name>
              <surname>Hancox</surname>
              <given-names>J.C.</given-names>
            </name>
          </person-group>
          <article-title>Acidosis impairs the protective role of hERG K<sup>+</sup> channels against premature stimulation</article-title>
          <source>J. Cardiovasc. Electrophysiol.</source>
          <volume>21</volume>
          <year>2010</year>
          <fpage>1160</fpage>
          <lpage>1169</lpage>
          <pub-id pub-id-type="pmid">20455975</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0175">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Long</surname>
              <given-names>S.B.</given-names>
            </name>
            <name>
              <surname>Tao</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>E.B.</given-names>
            </name>
            <name>
              <surname>MacKinnon</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Atomic structure of a voltage-dependent K<sup>+</sup> channel in a lipid membrane-like environment</article-title>
          <source>Nature</source>
          <volume>450</volume>
          <year>2007</year>
          <fpage>376</fpage>
          <lpage>382</lpage>
          <pub-id pub-id-type="pmid">18004376</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0180">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sanguinetti</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Mitcheson</surname>
              <given-names>J.S.</given-names>
            </name>
          </person-group>
          <article-title>Predicting drug-hERG channel interactions that cause acquired long QT syndrome</article-title>
          <source>Trends Pharmacol. Sci.</source>
          <volume>26</volume>
          <year>2005</year>
          <fpage>119</fpage>
          <lpage>124</lpage>
          <pub-id pub-id-type="pmid">15749156</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0185">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vandenberg</surname>
              <given-names>J.I.</given-names>
            </name>
            <name>
              <surname>Torres</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>Kuchel</surname>
              <given-names>P.W.</given-names>
            </name>
          </person-group>
          <article-title>The HERG K<sup>+</sup> channel: progress in understanding the molecular basis of its unusual gating kinetics</article-title>
          <source>Eur. Biophys. J.</source>
          <volume>33</volume>
          <year>2004</year>
          <fpage>89</fpage>
          <lpage>97</lpage>
          <pub-id pub-id-type="pmid">13680209</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0190">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Piper</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Sanguinetti</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Tristani-Firouzi</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Voltage sensor movement in the hERG K<sup>+</sup> channel</article-title>
          <source>Novartis Found. Symp.</source>
          <volume>266</volume>
          <year>2005</year>
          <fpage>46</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="pmid">16050261</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0195">
        <label>39</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferrer</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Rupp</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Piper</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Tristani-Firouzi</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>The S4–S5 linker directly couples voltage sensor movement to the activation gate in the human Ether-à-go-go-related gene (hERG) K<sup>+</sup> channel</article-title>
          <source>J. Biol. Chem.</source>
          <volume>281</volume>
          <year>2006</year>
          <fpage>12858</fpage>
          <lpage>12864</lpage>
          <pub-id pub-id-type="pmid">16524878</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0200">
        <label>40</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stansfeld</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Gedeck</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Gosling</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Cox</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Mitcheson</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Sutcliffe</surname>
              <given-names>M.J.</given-names>
            </name>
          </person-group>
          <article-title>Drug block of the hERG potassium channel: insight from modeling</article-title>
          <source>Proteins</source>
          <volume>68</volume>
          <year>2007</year>
          <fpage>568</fpage>
          <lpage>580</lpage>
          <pub-id pub-id-type="pmid">17444521</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0205">
        <label>41</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sanguinetti</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Tristani-Firouzi</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>hERG potassium channels and cardiac arrhythmia</article-title>
          <source>Nature</source>
          <volume>440</volume>
          <year>2006</year>
          <fpage>463</fpage>
          <lpage>469</lpage>
          <pub-id pub-id-type="pmid">16554806</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0210">
        <label>42</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Tseng</surname>
              <given-names>G.N.</given-names>
            </name>
          </person-group>
          <article-title>Gating charges in the activation and inactivation processes of the HERG channel</article-title>
          <source>J. General Physiol.</source>
          <volume>124</volume>
          <year>2004</year>
          <fpage>703</fpage>
          <lpage>718</lpage>
        </element-citation>
      </ref>
      <ref id="bb0215">
        <label>43</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Subbiah</surname>
              <given-names>R.N.</given-names>
            </name>
            <name>
              <surname>Clarke</surname>
              <given-names>C.E.</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>J.T.</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>Vandenberg</surname>
              <given-names>J.I.</given-names>
            </name>
          </person-group>
          <article-title>Molecular basis of slow activation of the human ether-á-go-go related gene potassium channel</article-title>
          <source>J. Physiol.</source>
          <volume>558</volume>
          <year>2004</year>
          <fpage>417</fpage>
          <lpage>431</lpage>
          <pub-id pub-id-type="pmid">15181157</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0220">
        <label>44</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Subbiah</surname>
              <given-names>R.N.</given-names>
            </name>
            <name>
              <surname>Kondo</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>Vandenberg</surname>
              <given-names>J.I.</given-names>
            </name>
          </person-group>
          <article-title>Tryptophan scanning mutagenesis of the HERG K<sup>+</sup> channel: the S4 domain is loosely packed and likely to be lipid exposed</article-title>
          <source>J. Physiol.</source>
          <volume>569</volume>
          <year>2005</year>
          <fpage>367</fpage>
          <lpage>379</lpage>
          <pub-id pub-id-type="pmid">16166152</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0225">
        <label>45</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Piper</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Hinz</surname>
              <given-names>W.A.</given-names>
            </name>
            <name>
              <surname>Tallurri</surname>
              <given-names>C.K.</given-names>
            </name>
            <name>
              <surname>Sanguinetti</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Tristani-Firouzi</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Regional specificity of human ether-a-go-go-related gene channel activation and inactivation gating</article-title>
          <source>J. Biol. Chem.</source>
          <volume>280</volume>
          <year>2005</year>
          <fpage>7206</fpage>
          <lpage>7217</lpage>
          <pub-id pub-id-type="pmid">15528201</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0230">
        <label>46</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sansom</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Weinstein</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Hinges, swivels and switches: the role of prolines in signalling via transmembrane alpha-helices</article-title>
          <source>Trends Pharmacol. Sci.</source>
          <volume>21</volume>
          <year>2000</year>
          <fpage>445</fpage>
          <lpage>451</lpage>
          <pub-id pub-id-type="pmid">11121576</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0235">
        <label>47</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Tseng</surname>
              <given-names>G.N.</given-names>
            </name>
          </person-group>
          <article-title>Structural and functional role of the extracellular S5-P linker in the HERG potassium channel</article-title>
          <source>J. Gen. Physiol.</source>
          <volume>120</volume>
          <year>2002</year>
          <fpage>723</fpage>
          <lpage>737</lpage>
          <pub-id pub-id-type="pmid">12407082</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0240">
        <label>48</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Mahaut-Smith</surname>
              <given-names>M.P.</given-names>
            </name>
            <name>
              <surname>Varghese</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>C.L.</given-names>
            </name>
            <name>
              <surname>Kemp</surname>
              <given-names>P.R.</given-names>
            </name>
            <name>
              <surname>Vandenberg</surname>
              <given-names>J.I.</given-names>
            </name>
          </person-group>
          <article-title>Effects of premature stimulation on HERG K<sup>+</sup> channels</article-title>
          <source>J. Physiol.</source>
          <volume>537</volume>
          <year>2001</year>
          <fpage>843</fpage>
          <lpage>851</lpage>
          <pub-id pub-id-type="pmid">11744759</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0245">
        <label>49</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Laskowski</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>MacArthur</surname>
              <given-names>M.W.</given-names>
            </name>
            <name>
              <surname>Moss</surname>
              <given-names>D.S.</given-names>
            </name>
            <name>
              <surname>Thornton</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>PROCHECK: a program to check the stereochemical quality of protein structure</article-title>
          <source>J. Appl. Cryst.</source>
          <volume>26</volume>
          <year>1993</year>
          <fpage>283</fpage>
          <lpage>291</lpage>
        </element-citation>
      </ref>
      <ref id="bb0250">
        <label>50</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>S.Y.</given-names>
            </name>
            <name>
              <surname>Banerjee</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>MacKinnon</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Two separate interfaces between the voltage sensor and pore are required for the function of voltage-dependent K<sup>+</sup> channels</article-title>
          <source>PLoS Biol.</source>
          <volume>7</volume>
          <year>2009</year>
          <fpage>e1000047</fpage>
        </element-citation>
      </ref>
      <ref id="bb0255">
        <label>51</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ju</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Pages</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Riek</surname>
              <given-names>R.P.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Torres</surname>
              <given-names>A.M.</given-names>
            </name>
            <name>
              <surname>Bansal</surname>
              <given-names>P.S.</given-names>
            </name>
            <name>
              <surname>Kuyucak</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Kuchel</surname>
              <given-names>P.W.</given-names>
            </name>
            <name>
              <surname>Vandenberg</surname>
              <given-names>J.I.</given-names>
            </name>
          </person-group>
          <article-title>The pore domain outer helix contributes to both activation and inactivation of the HERG K<sup>+</sup> channel</article-title>
          <source>J. Biol. Chem.</source>
          <volume>284</volume>
          <year>2009</year>
          <fpage>1000</fpage>
          <lpage>1008</lpage>
          <pub-id pub-id-type="pmid">18996846</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0260">
        <label>52</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zou</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>Q.P.</given-names>
            </name>
            <name>
              <surname>Sanguinetti</surname>
              <given-names>M.C.</given-names>
            </name>
          </person-group>
          <article-title>A mutation in the pore region of HERG K<sup>+</sup> channels expressed in <italic>Xenopus</italic> oocytes reduces rectification by shifting the voltage dependence of inactivation</article-title>
          <source>J. Physiol.</source>
          <volume>509</volume>
          <year>1998</year>
          <fpage>129</fpage>
          <lpage>137</lpage>
          <pub-id pub-id-type="pmid">9547387</pub-id>
        </element-citation>
      </ref>
      <ref id="bb0265">
        <label>53</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duncan</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>McPate</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Ridley</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>James</surname>
              <given-names>A.F.</given-names>
            </name>
            <name>
              <surname>Leishman</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Leaney</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Witchel</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Hancox</surname>
              <given-names>J.C.</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of the HERG potassium channel by the tricyclic antidepressant doxepin</article-title>
          <source>Biochem. Pharmacol.</source>
          <volume>74</volume>
          <year>2007</year>
          <fpage>425</fpage>
          <lpage>437</lpage>
          <pub-id pub-id-type="pmid">17560554</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <ack>
      <title>Acknowledgements</title>
      <p>The authors thank Mrs Lesley Arberry for technical assistance, Dr Aziza El Harchi for statistical discussion and the British Heart Foundation for funding (grant numbers PG 06/042, and PG 10/017).</p>
    </ack>
  </back>
  <floats-group>
    <fig id="f0005">
      <label>Fig. 1</label>
      <caption>
        <p>(A) Amino acid sequence alignment for region encompassing zebrafish (zERG) L499 with human (hERG), horse (eERG), dog (dERG), rat (rERG) and mouse (mERG). Domains S4, S5 and the S4–S5 linker are indicated below the sequences. The L at position 532 of hERG is highly conserved across species and is highlighted in gray. (B) Example current traces for WT (upper panel of Bi) and mutant L532P I<sub>hERG</sub> (upper panel of Bii) with corresponding voltage protocol used shown in the lower panels. Note that the current scales in Bi and Bii differ. Inset to Bii shows higher gain representation of L532P tail current.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="f0010">
      <label>Fig. 2</label>
      <caption>
        <p>Current–voltage (I–V) relationship for WT and L532P I<sub>hERG</sub>. (A, B) Upper panels show representative families of currents from WT hERG (A) and L532P hERG (B), elicited by the voltage protocol shown in the lower panel (start-to-start interval of 12 s between successive voltage steps). For clarity only selected sweeps are shown; note that the current scales in A and B differ. (C) Mean I–V relations for end-pulse current (n = 7 for WT and n = 9 for L532P). (D) Mean normalized tail current I–V relations; for each of WT (n = 7) and L532P (n = 9) data were normalized to the maximal current recorded during the protocol. (* denotes statistic significance of <italic>P</italic> &lt; 0.05, ** of <italic>P</italic> ≤ 0.01, *** of <italic>P</italic> ≤ 0.005, **** of <italic>P</italic> ≤ 0.001).</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="f0015">
      <label>Fig. 3</label>
      <caption>
        <p>Fully activated I–V relationships, I<sub>hERG</sub> deactivation and activation time-course for WT and L532P. (Aii) Shows the protocol used to elicit the families of currents for WT I<sub>hERG</sub> in Ai and for L532P I<sub>hERG</sub> in B, from which the normalized fully activated I–V relations (C) were obtained (WT, n = 6; L532P, n = 9). In Ai and B selected currents are shown for clarity; note different current scales used. For ‘C’, peak I<sub>tails</sub> at each repolarization potential were normalized to the peak outward I<sub>tail</sub> during the protocol. (D, E) Fast and slow time-constants of deactivation from bi-exponential fits to the deactivating component of tail currents at each repolarization potential. (F) Plots of the proportion of fast deactivation against repolarization voltage in WT and L532P. (* denotes statistic significance of <italic>P</italic> &lt; 0.05, ** of <italic>P</italic> ≤ 0.01, *** of <italic>P</italic> ≤ 0.005, **** of <italic>P</italic> ≤ 0.001, for D–F, WT n = 6; L532P n = 9).(G) Activation time course of WT and L532P I<sub>hERG</sub> at + 20 mV elicited by an envelope of tails protocol shown in inset (WT n = 6; L532P n = 9).</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <fig id="f0020">
      <label>Fig. 4</label>
      <caption>
        <p>Voltage and time-dependence of inactivation for WT and L532P. (A, B) show the voltage protocol used to determine the I<sub>hERG</sub> availability for WT (A) and L532P (B) I<sub>hERG</sub>. (C, D) Upper traces show representative records of WT and L532P I<sub>hERG</sub> respectively, focusing on the current profile during the second and start of the third steps of the protocol as shown in lower panel. Note that the current scales in C and D differ. (E) I<sub>hERG</sub> availability plots for WT (n = 9) and L532P (n = 8) hERG. (F) Recovery from inactivation time-course for WT and L532P hERG (protocol shown as inset). The dashed gray line denotes mono-exponential fit to WT data (n = 9). The solid line denotes mono-exponential fit to L532P data, with the dotted line connecting these data at successive time points (n = 8).</p>
      </caption>
      <graphic xlink:href="gr4"/>
    </fig>
    <fig id="f0025">
      <label>Fig. 5</label>
      <caption>
        <p>I<sub>hERG</sub> during ventricular action potential voltage-clamp (AP clamp) for WT and L532P hERG (Ai, Aii). Ventricular AP command waveform overlying I<sub>hERG</sub> profiles for WT (Ai) and L532P (Aii). In Aii WT current profile is superimposed (in gray) on that for L532P current (black). For each of Ai and Aii, currents are normalized to peak current seen during the waveform (I/I<sub>max</sub>). (B, C) Mean normalized plots of instantaneous current–voltage (I–V) relations for I<sub>hERG</sub> during AP repolarization for WT (B; n = 7) and L532P (C; n = 8) I<sub>hERG</sub>. The arrows indicate the direction of AP repolarization.</p>
      </caption>
      <graphic xlink:href="gr5"/>
    </fig>
    <fig id="f0030">
      <label>Fig. 6</label>
      <caption>
        <p>Comparison of inhibition by dronedarone (Droned) of WT and L532P I<sub><italic>hERG</italic></sub>. (A) Upper traces show WT I<sub>hERG</sub> before and after 10 minute application of 300 nM Droned; protocol shown in lower trace. (B) Upper traces show L532P I<sub>hERG</sub> before and after 10 minute application of 300 nM Droned, with an inset showing tail current on higher gain; lower trace shows voltage protocol. Note that the current scales in A and B differ. (C) Concentration–response relations for inhibition of WT and L532P I<sub><italic>hERG</italic></sub> tails by Droned. At least five cells were used to test each drug concentration.</p>
      </caption>
      <graphic xlink:href="gr6"/>
    </fig>
    <fig id="f0035">
      <label>Fig. 7</label>
      <caption>
        <p>Location of L532 in the context of the Kv1.2/2.1 chimera-based model of hERG. (A) Homology between hERG and the Kv1.2/2.1 chimera in and around the S4 sequence that was used for construction of this part of the hERG model. Amino acid identities are red; similarities are blue. The schematic above the sequences refers to the location of structural elements in the hERG model. (B) Close up of a hERG homology model based on the crystal structure of the Kv1.2/Kv2.1 paddle chimera, illustrating juxtaposition of the voltage sensor domain of one subunit (cyan/blue) with the pore domain of an adjacent subunit (pink/mauve). The L532 residue (red) in the S4 helix is oriented toward the S5 helix of an adjacent subunit.</p>
      </caption>
      <graphic xlink:href="gr7"/>
    </fig>
    <table-wrap id="t0005" position="float">
      <label>Table 1</label>
      <caption>
        <p>Comparison of biophysical parameters for WT and L532P hERG.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left">Property</th>
            <th align="left">WT</th>
            <th align="left">L532P</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left">V<sub>act 0.5</sub>(mV)</td>
            <td align="left">− 16.6 ± 2.3</td>
            <td align="left">19.2 ± 2.8</td>
          </tr>
          <tr>
            <td rowspan="2" align="left"><italic>k</italic> (activation, mV)</td>
            <td align="left">6.8 ± 0.3</td>
            <td align="left">12.4 ± 0.9</td>
          </tr>
          <tr>
            <td align="left">(n = 7 for both)</td>
            <td align="left">(n = 9 for both)</td>
          </tr>
          <tr>
            <td rowspan="2" align="left">τ<sub>act</sub> (ms)</td>
            <td align="left">67.9 ± 6.1</td>
            <td align="left">32.6 ± 2.2</td>
          </tr>
          <tr>
            <td align="left">(n = 9)</td>
            <td align="left">(n = 6)</td>
          </tr>
          <tr>
            <td rowspan="2" align="left">E<sub>rev</sub> (mV)</td>
            <td align="left">− 84.3 ± 0.9</td>
            <td align="left">− 80.3 ± 0.8</td>
          </tr>
          <tr>
            <td align="left">(n = 6)</td>
            <td align="left">(n = 9)</td>
          </tr>
          <tr>
            <td align="left">V<sub>inact0.5</sub>(mV)</td>
            <td align="left">− 70.3 ± 1.7</td>
            <td align="left">− 38.7 ± 3.7</td>
          </tr>
          <tr>
            <td rowspan="2" align="left"><italic>k</italic> (inactivation,mV)</td>
            <td align="left">19.6 ± 0.5</td>
            <td align="left">28.7 ± 2.8</td>
          </tr>
          <tr>
            <td align="left">(n = 9 for both)</td>
            <td align="left">(n = 6 for both)</td>
          </tr>
          <tr>
            <td rowspan="2" align="left">τ<sub>inact</sub> (ms)</td>
            <td align="left">1.34 ± 0.13</td>
            <td align="left">1.0 ± 0.06</td>
          </tr>
          <tr>
            <td align="left">(n = 9)</td>
            <td align="left">(n = 6)</td>
          </tr>
          <tr>
            <td rowspan="2" align="left">τ<sub>rec</sub> (ms)</td>
            <td align="left">1.92 ± 0.07</td>
            <td align="left">1.43 ± 0.12</td>
          </tr>
          <tr>
            <td align="left">(n = 10)</td>
            <td align="left">(n = 11)</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p>Abbreviations: V<sub>act 0.5</sub>, half-maximal activation voltage; τ<sub>act</sub>, time constant of activation; E<sub>rev</sub>, reversal potential; V<sub>inact0.5</sub>, half-maximal inactivation voltage; <italic>k</italic>, slope factor for activation or inactivation relationship; τ<sub>inact</sub>, time constant of inactivation; τ<sub>rec</sub>, time constant of recovery from inactivation; n = number of experimental replicates. Data are presented as mean ± s.e. mean.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>